Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Triandafillos P. Didangelos"'
Autor:
Natalia Papastergiou, Konstantia Psianou, Fotios Iliadis, Christos Savopoulos, Konstantinos Tziomalos, M. Baltatzi, Apostolos I. Hatzitolios, Marianna Spanou, Elias Efthymiou, Triandafillos P. Didangelos
Publikováno v:
Diabetes Technology & Therapeutics. 15:475-480
Impaired fasting glucose (IFG) is frequently present in hypertensive patients and might be induced or aggravated by antihypertensive treatment. However, it is unclear whether IFG is associated with increased cardiovascular risk in this population.We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b8e237bdc5b1bf570c656e495c84882c
https://doi.org/10.1089/dia.2012.0336
https://doi.org/10.1089/dia.2012.0336
Autor:
Anna I. Kakafika, Dimitri P. Mikhailidis, Andrew K. Burroughs, Evangelos Liberopoulos, Triandafillos P. Didangelos, Asterios Karagiannis, Olga Giouleme, Konstantinos Tziomalos, Moses Elisaf, Vasilios G. Athyros
Publikováno v:
Current Medical Research and Opinion. 22:873-883
Non-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of the metabolic syndrome (MetS). There is no established treatment for NAFLD.To evaluate a multifactorial intervention in the treatment of NAFLD.A prospective, open-label, random
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b70253eeb612cd3a9053abfc99812c92
https://doi.org/10.1185/030079906x104696
https://doi.org/10.1185/030079906x104696
Autor:
Vasilios G. Athyros, Athanasios A. Papageorgiou, Dimitri P. Mikhailidis, Athanasios N. Symeonidis, Moses Elisaf, Stella S. Daskalopoulou, Triandafillos P. Didangelos, Anna I. Kakafika, Emmanuel S. Ganotakis
Publikováno v:
Current Medical Research and Opinion. 20:1691-1701
To estimate the prevalence of vascular disease (coronary heart disease/stroke/peripheral arterial disease) in individuals with the metabolic syndrome (MetSyn) with or without diabetes mellitus (DM) when compared with subjects without the MetSyn.A cro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a87888188fafcb64e7ff6259db9ab581
https://doi.org/10.1185/030079904x5599
https://doi.org/10.1185/030079904x5599
Autor:
VI Bouloukos, AN Pehlivanidis, Triandafillos P. Didangelos, Athanasios A. Papageorgiou, Dimitrios P. Mikhailidis, Vasilios G. Athyros, Athanasios N. Symeonidis
Publikováno v:
Angiology. 54:679-690
This is a prospective evaluation of the effect of structured care of dyslipidemia with atorvas tatin (strict implementation of guidelines) versus usual care (physician's standard of care) on morbidity and mortality of patients with coronary heart dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9b7e52c26f21edbae78ae3517d79defe
https://doi.org/10.1177/000331970305400607
https://doi.org/10.1177/000331970305400607
Autor:
Vasilios G. Athyros, Athanasios G. Kontopoulos, Dimitrios F. Kranitsas, Haris A. Hatzikonstandinou, Athanasios A. Papageorgiou, Maria V. Carina, Triandafillos P. Didangelos
Publikováno v:
The American Journal of Cardiology. 80:608-613
No monotherapy is able to tackle effectively all atherogenic features of familial combined hyperlipidemia: high low-density lipoprotein (LDL) cholesterol, triglycerides (TG), and plasma fibrinogen, as well as low high-density lipoprotein (HDL) choles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1f19f950a4145abdbf476e65b073df23
https://doi.org/10.1016/s0002-9149(97)00430-x
https://doi.org/10.1016/s0002-9149(97)00430-x
Autor:
Triandafillos P. Didangelos, Konstantinos Tziomalos, George Giannakoulas, Dimitrios T. Karamitsos, Apostolos I. Hatzitolios, Anestis Zantidis
Publikováno v:
Journal of diabetes and its complications. 23(4)
Cerebrovascular disease (CeVD) represents a major cause of morbidity and mortality worldwide. Diabetes mellitus (DM) represents an independent risk factor for CeVD. The aim of the present review is to describe the epidemiology of CeVD in patients wit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61a1c7200846c544fd953b6bc37fd148
https://pubmed.ncbi.nlm.nih.gov/18358748
https://pubmed.ncbi.nlm.nih.gov/18358748
Autor:
Dimitri P. Mikhailidis, Drosia Kleta, Anna I. Kakafika, Athanasios A. Papageorgiou, Athanasia Peletidou, Moses Elisaf, Triandafillos P. Didangelos, Vasilios G. Athyros, Asterios Karagiannis, Konstantinos Tziomalos
Publikováno v:
Metabolism: clinical and experimental. 54(8)
There are no prospective data on the effect of a multitargeted treatment approach on cardiovascular disease (CVD) risk reduction in nondiabetic patients with metabolic syndrome (MetS). Furthermore, the optimal hypolipidemic drug treatment in these pa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d0f829d0d782b9921164785ce4edc37
https://pubmed.ncbi.nlm.nih.gov/16092057
https://pubmed.ncbi.nlm.nih.gov/16092057
Autor:
Vasilios G, Athyros, Athanasios A, Papageorgiou, Athanasios N, Symeonidis, Triandafillos P, Didangelos, Anthimos N, Pehlivanidis, Vasilios I, Bouloukos, Dimitrios P, Mikhailidis
Publikováno v:
Angiology. 54(6)
This is a prospective evaluation of the effect of structured care of dyslipidemia with atorvastatin (strict implementation of guidelines) versus usual care (physician's standard of care) on morbidity and mortality of patients with coronary heart dise
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::098d88d7375ebf764e2d329bf67e3f84
https://pubmed.ncbi.nlm.nih.gov/14666956
https://pubmed.ncbi.nlm.nih.gov/14666956